Nasal vaccination: A non-invasive vaccine delivery method that holds great promise for the future

Advanced Drug Delivery Reviews

Volumn 51, Issue 1-3, 2001, Pages 1-3

  Illum, L ^a  

^a Drug Delivery and Clinical Research Centre Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BACTERIAL TOXIN; CHITOSAN; GAG PROTEIN; INFLUENZA VACCINE; LIPOSOME; MICROSPHERE; NASAL FLU; VACCINE;

ANTIBODY RESPONSE; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; EDITORIAL; GRAM NEGATIVE INFECTION; IMMUNE RESPONSE; INFLUENZA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TECHNIQUE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS ATTENUATION; VIRUS NUCLEOCAPSID;

ADMINISTRATION, INTRANASAL; ANIMALS; HUMANS; VACCINES;

EID: 0035940313     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00176-4     Document Type: Editorial

References (10)

1. The bare skin and the nose as non-invasive routes for administering peptide vaccines
2. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity
3. Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies
4. DNA vaccination against respiratory influenza virus infection
5. Protection against respiratory syncytial virus (RSV) elicited in by plasmid DNA immunisation encoding a secreted RSV G pre-derived antigen
6. Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
7. Nasal vaccination with attenuated Salmonella typhimurium strains expressing the hepatitis B nucleocapsid: Dose response analysis
8. Mucosal immunity in the lung and upper airway
9. Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization
10. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization